Skip to main content
Clinical Trials/IRCT20220423054625N1
IRCT20220423054625N1
Not yet recruiting
Phase 3

Comparison of clinical outcomes after combined therapy of bevacizumab intravitreal injection and topical diclofenac with bevacizumab intravitreal injection alone in diabetic macular edema

Oroumia University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Diabetic macular edema.
Sponsor
Oroumia University of Medical Sciences
Enrollment
50
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Diabetic patients with non\-proliferative diabetic retinopathy and diabetic macular edema
  • Age over 18 years

Exclusion Criteria

  • Glaucoma patients
  • Patients with a history of laser therapy
  • Patients with significant media opacity
  • Infection and inflammation of the anterior canine of the eye

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Comparison of the effects of combined treatment of laryngeal manual therapy with Kinesio taping and laryngeal manual therapy alone in improving vocalic symptoms in patients with muscle tension dysphonia.Muscle tension dysphonia.DysphoniaR49.0
IRCT20210303050570N1Semnan University of Medical Sciences20
Not yet recruiting
Phase 4
Comparison of ultima smart toric intraocular lens with tecnis toric intraocular lensHealth Condition 1: H251- Age-related nuclear cataract
CTRI/2019/05/019153Care Group Sight Solution LLP
Not yet recruiting
Phase 3
A clinical trail to study and compare the effects of two combinations of drugs,Aragwadh amrutadi vati with Dhanyakadi lepa and Guduchyadi Vati with Dhanyakadi lepa in Patinets having Mukhadushika.Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
CTRI/2021/02/031443Sumatibhai Shah Ayurved Mahavidyalaya
Not yet recruiting
Phase 2
To compare the effect of combined treatment with chloroquine and olopatadine eye drops with treatment with olopatadine eye drops alone in patients with allergic conjunctivitisHealth Condition 1: H101- Acute atopic conjunctivitis
CTRI/2019/05/019304RP Centre
Recruiting
Phase 4
Treatment of gum loss in gum disease individuals using animal derived membrane along with patients blood derived substancesHealth Condition 1: K060- Gingival recession
CTRI/2024/05/067734kiran choudhary